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Abstract 
Background: Immune responses in allergic diseases begin with allergen sensitization, which usually occurs in child‑
hood. Allergen sensitization involves a complex interplay of genetic and environmental factors, and sensitization 
patterns may change with age.
Objective: To determine the predictors of allergen sensitization in the first 3 years of life in the growing up in Singa‑
pore towards healthy outcomes (GUSTO) prospective birth cohort study.
Methods: Interviewers collected information on demographics, family history of allergy, social and lifestyle fac‑
tors, and the child’s health. We analyzed data from 849 children who completed skin prick testing (SPT) to inhalant 
allergens (house dust mites: Dermatophagoides pteronyssinus, Dermatophagoides farinae, and Blomia tropicalis) and 
food allergens (egg, peanut and cow’s milk) to assess risk factors for allergen sensitization at 18 months. To ensure that 
clinical phenotypes preceded allergen sensitization, we also analyzed data from 649 children who had a negative skin 
prick test at 18 months and completed skin prick testing at 36 months.
Results: We observed a significant association between eczema reported before 18 months and a positive SPT at 
18 months [aOR 4.5 (1.9–10.7)]. Ninety‑five (14.6 %) children with negative SPTs at 18 months developed positive tests 
at 36 months. Onset of eczema before 18 months was associated with an increased risk of new allergen sensitiza‑
tion at 36 months among children non‑sensitized at 18 months [aOR 3.4 (1.2–9.3)]. An association was seen between 
wheeze reported before 18 months and new allergen sensitization at 36 months [aOR 3.2 (1.1–9.1)]. We found no 
significant association, however, between rhinitis reported before 18 months and new allergen sensitization at 
36 months.
Conclusions: Early onset of eczema and wheeze are risk factors for later allergen sensitization, suggesting a possible 
increased susceptibility to allergen exposure through an impaired skin barrier or defective airway epithelium.
Trial registration NCT01174875 Registered 1 July 2010, retrospectively registered
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Background
Immune responses in allergic diseases begin with aller-
gen sensitization. Allergen sensitization involves a com-
plex interplay of genetic and environmental factors, and 
sensitization patterns have been reported to change with 
age [1–3]. A cross-sectional study on the sensitization 
pattern in Singapore was conducted more than 10 years 
ago in a group of 75 children below the age of 3 years who 
have symptoms suggestive of atopic disorders [4]. In this 
group of children, the prevalence of cow’s milk sensitiza-
tion was the highest at 45.9 %, followed by egg white at 
38.7 % and dustmites (31.4 % to Dermatophagoides ptero-
nyssinus, and 25.5 % to Blomia tropicalis) [4].
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Given the changing environment, we evaluated risk 
factors of allergen sensitization in the first 3 years of life 
among Singapore children participating in a birth cohort 
study. To our knowledge, this is the first prospective 
study in Asia to assess risk factors for allergen sensitiza-
tion in the first 3 years of life.
In addition, allergic diseases such as eczema, rhinitis 
and wheeze that occur in early childhood may be with-
out allergen sensitization [5]. However, knowledge about 
the association between early clinical phenotypes and 
the development of subsequent allergen sensitization 
is limited, as most studies have not assessed non-sensi-
tized children, but have instead analyzed the association 
between early allergen sensitization and the subsequent 
development of allergic diseases [6, 7]. The aim of this 
study is to study the associations between the clinical 
phenotypes and the development of allergen sensitization 
in the first 3 years of life. We hypothesized that clinical 




The methodology of the GUSTO growth cohort study 
has been previously described [8, 9]. Briefly, we recruited 
healthy pregnant mothers who agreed to the follow-up 
of their offspring. Interviewers gathered information 
on demographics, family history of allergy, social and 
lifestyle factors and the child’s health. Definitions were 
standardized in questionnaires administered at 3  weeks 
and 3, 6, 9, 12, 15, 18, 24 and 36  months and based on 
the modified International Study of Asthma and Allergies 
in Children (ISAAC) questionnaire to ensure consistency 
during interviews and home visits. Presence of eczema 
was based on the answer to the written question: “Has 
your child ever been diagnosed with eczema?” “Wheez-
ing” was based on a positive answer to the written ques-
tion “Has your child ever wheezed?”, while “rhinitis” was 
based on a positive response to the question “Has your 
child ever had sneezing, running nose, blocked or con-
gested nose, snoring or noisy breathing during sleep or 
when awake that has lasted for 2 or more weeks dura-
tion?” Study team members telephoned the mothers who 
reported rhinitis to collect information on the number of 
episodes of rhinitis and the duration of rhinitis. A case 
prior to 18 months required a single episode that lasted 
for at least 4  weeks or two or more episodes each last-
ing at least 2 weeks. New cases of rhinitis after 18 months 
were defined by one or more episodes lasting at least 
2 weeks.
Classification of breastfeeding has been previously 
described [10]. High breastfeeding was defined by exclu-
sive or predominant breastfeeding for at least 4 months, 
with subsequent partial breastfeeding to at least 
6 months, while low breastfeeding was defined as exclu-
sive formula feeding or weaning before 3 months. Inter-
mediate breastfeeding was defined as breastfeeding to at 
least 3 months but without meeting the criteria for high 
breastfeeding.
Skin prick testing
Skin prick testing (SPT) to inhalant allergens (house dust 
mites D. pteronyssinus, Dermatophagoides farinae, and 
B. tropicalis) and food allergens (egg, peanut and cow’s 
milk) was carried out at both 18–36  months. All of the 
allergens for skin prick testing were obtained from Greer 
Laboratories (Lenoir, NC, USA), except for B. tropicalis, 
which was obtained from our laboratory. B. tropicalis 
extract was prepared as previously described [11]. Briefly, 
liquid nitrogen frozen cultured mites were ground in a 
mortar. Protein extraction was performed using phos-
phate-buffered saline(PBS) containing 1  mM phenyl-
methylsulphonyl fluoride (Sigma) and 1  mM EDTA at 
4 °C overnight. The extract was filtered through 0.22 mm 
membrane and quantified by Pierce™ BCA Protein Assay 
(ThermoFisher), 200 μg/ml of crude mite extract in 50 % 
glycerol buffer was prepared.
All tests were interpreted as positive if the wheal was at 
least 3 mm, and a child was considered as SPT-positive if 
any one or more of the individual tests was positive with 
a positive reaction to histamine (positive control) and a 
negative reaction to saline (negative control).
Study populations
We carried out separate analyses in two study popula-
tions. The first comprised all children who had com-
pleted skin prick testing at 18  months and was used to 
assess predictors of allergen sensitization at 18  months. 
The second (a subpopulation of the first) comprised chil-
dren with negative skin prick tests for all allergens at 
18  months and was used to analyze clinical phenotypes 
that affected the subsequent development of new allergen 
sensitization at 36 months.
Statistical analysis
Statistical analysis was carried out using SPSS version 
20.0 (IBM SPSS Statistics, Armonk, NY). The differ-
ences in demographic characteristics between the study 
populations were tested by Chi-square tests. The p value 
represents an overall comparison among the 3 groups, in 
terms of the demographic variable. A p value <0.05 indi-
cates that there is a difference among the 3 groups for the 
demographic variable. Associations between antecedent 
predictors and subsequent allergen sensitization were 
estimated using multivariable logistic regression adjust-
ing for sex, ethnicity, maternal education, family history 
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of allergy, mode of delivery (vaginal vs cesarean), breast-
feeding, antibiotic consumption in the first 6 months of 
life, dog ownership, living near an expressway, and expo-
sure to tobacco smoke in the home at 12 months. These 
confounders were selected by a review of the literature 
[12–14].
Results
Of the 1247 subjects recruited into GUSTO, 849 com-
pleted skin prick testing at 18 months and comprised the 
first study population. Of the 849 subjects, 477 (56.2 %) 
were Chinese, 440 (51.8  %) were male and 505 (59.5  %) 
were born to mothers with at least 12 years of education. 
No significant differences in these characteristics were 
observed between subjects who completed the skin prick 
testing and those who did not (data not shown). A total of 
649 children had a negative SPT at 18 months and com-
pleted a second SPT at 36 months. Of these, 367 (56.5 %) 
were Chinese, 335 (51.6  %) were male and 380 (58.6  %) 
were born to mothers with at least 12 years of education.
Table  1 compares the characteristics of children who 
remained unsensitized at both 18–36 months, those sen-
sitized at 18 months and those with new sensitization at 
36 months.
Prevalence of allergen sensitization at 18–36 months
The positive SPT rate increased from 115 (13.5  %) at 
18  months to 200 (23.4  %) at 36  months. Similarly, the 
positive SPT rate to dust mites increased from 95 (11.2 %) 
at 18 months to 194 (22.6 %) at 36 months. In contrast, 
positive SPT to one or more food allergens decreased 
from 38 (4.5 %) at 18 months to 18 (2.1 %) at 36 months.
At 18  months, 95 subjects (11.2  %) showed a positive 
SPT to one or more house dust mite: 71 (8.4  %) to D. 
pteronyssinus, 57 (6.7 %) to D. farinae and 8 (0.9 %) to B. 
tropicalis; 38 (4.5 %) subjects had a positive SPT to food 
allergens: 6 (0.7  %) to cow’s milk, 11 (1.3  %) to peanut 
and 30 (3.5  %) to egg. Out of these 38 subjects, 11 had 
reported clinical food allergies: 1 to cow’s milk, 1 to egg 
and peanut, 8 to egg and 1 to peanut. These subjects with 
clinical food allergies also have supportive SPT data.
Ninety-six (14.7  %) children with negative SPTs at 
18 months developed positive tests at 36 months: 92 sub-
jects (14.2 %) to one or more dust mites, 76 (11.8 %) to D. 
pteronyssinus, 58 (8.9 %) to D. farinae and 9 (1.4 %) to B. 
tropicalis. New food allergen sensitization was observed 
to peanut in 3 (0.5 %) and to egg in 1 (0.2 %). However 
these subjects with new food sensitizations did not 
report clinical symptoms of food allergies.
Predictors of allergen sensitization at 18 months
We found a significant association between eczema 
reported before 18  months and a positive SPT at 
18  months [aOR 4.5 (1.9–10.7), Table  2] after adjusting 
for sex, ethnicity, maternal education, family history of 
allergy, mode of delivery, breastfeeding, antibiotic con-
sumption in the first 6 months of life, owning a dog, liv-
ing near an expressway and exposure to tobacco smoke at 
12 months of life. There was also a significant association 
between rhinitis reported before 18 months and a posi-
tive SPT [aOR 2.8 (1.1–7.3), Table  2] after adjusting for 
confounders. No significant associations were observed 
between wheeze reported before 18  months and aller-
gen sensitization at 18 months. Further analysis showed 
that eczema reported before 18 months was significantly 
associated with both inhalant allergen sensitization [aOR 
3.7 (1.5–9.4)] and food allergen sensitization [aOR 7.6 
(1.9–30.7)] (data not shown). No significant associa-
tions were observed between wheeze or rhinitis reported 
before 18 months and inhalant or food allergen sensitiza-
tion at 18 months.
Predictors of new cases of allergen sensitization 
at 36 months
Eczema reported before 18  months [aOR 3.4 (1.2–9.3)] 
was associated with an increased risk of new allergen 
sensitization at 36  months among children with nega-
tive SPTs at 18 months (Table 3). An association was also 
observed between wheeze reported before 18  months 
and new allergen sensitization at 36  months [aOR 3.2 
(1.1–9.1)]. Although we found no significant association 
between rhinitis reported before 18  months and new 
allergen sensitization at 36 months, rhinitis first reported 
after 18  months increased the risk of development of 
allergen sensitization at 36  months [aOR 3.0 (1.05–8.3), 
Table  3]. For subjects with onset of rhinitis in the first 
18 months, 25.7 % had positive SPT to house dust mites 
at 36  months. For subjects with onset of rhinitis after 
18 months, 31.5 % had a positive SPT to house dust mites 
at 36 months. No significant associations were observed 
between onset of wheeze or eczema first reported after 
18 months and allergen sensitization at 36 months. Sepa-
rate analysis of inhalant allergen and food allergen sensi-
tization showed a significant association between wheeze 
reported before 18  months and new inhalant sensitiza-
tion at 36  months [aOR 3.2 (1.1–9.1)] and a borderline 
association between eczema reported before 18  months 
and new inhalant sensitization at 36  months [aOR 2.9 
(1.0–8.3), p  =  0.052] (data not shown). Rhinitis first 
reported after 18 months also increased the risk of devel-
oping new inhalant sensitization at 36 months [aOR 2.9 
(1.05–8.3)] while no significant associations were seen 
between onset of wheeze and eczema first reported after 
18  months and new inhalant allergen sensitization at 
36 months. The number of subjects with new food aller-
gen sensitization at 36 months was too small to analyze.
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Discussion
Similar to the changes we observed in sensitization, other 
cohort studies have also noted a marked increase over the 
first 6 years of life in sensitization to inhalant allergens: 
Table 1 Comparison of study groups




New sensitization at M36 among  
children non-sensitized at M18
p value
n (%) n (%) n (%)
Sex
 Female 270 (48.7) 48 (41.7) 43 (45.7) 0.4
 Male 284 (51.3) 67 (58.3) 51 (54.3)
Ethnicity
 Chinese 305 (55.1) 66 (57.4) 62 (65.3) 0.049
 Malay 147 (26.5) 38 (33.0) 19 (20.0)
 Indian 102 (18.4) 11 (9.6) 14 (14.7)
No family history of allergy 184 (51.1) 35 (43.8) 24 (40.7) 0.2
Family history of allergy 176 (48.9) 45 (56.2) 35 (59.3)
Vaginal delivery 385 (69.5) 77 (67.0) 74 (79.6) 0.1
Non‑vaginal delivery 169 (30.5) 38 (33.0) 19 (20.4)
Low breastfeeding 242 (45.2) 37 (33.9) 26 (29.2) <0.01
Intermediate breastfeeding 227 (42.4) 55 (50.5) 55 (61.8)
High breastfeeding 66 (12.3) 17 (15.6) 8 (9.0)
No antibiotic consumption in the first 
6 months
437 (84.2) 98 (89.1) 76 (88.4) 0.3
Antibiotic consumption in the first 6 months 82 (15.8) 12 (10.9) 10 (11.6)
No dog ownership at 12 months 281 (92.7) 55 (94.8) 57 (98.3) 0.3
Dog ownership at 12 months 22 (7.3) 3 (5.2) 1 (1.7)
Not staying near an expressway at 12 months 252 (83.4) 43 (74.1) 43 (74.1) 0.1
Staying near an expressway at 12 months 50 (16.6) 15 (25.9) 15 (25.9)
No exposure to smoke at 12 months 196 (64.3) 43 (72.9) 42 (72.4) 0.3
Exposure to smoke at 12 months 109 (35.7) 16 (27.1) 16 (27.6)
Maternal education levels ≤12 years 232 (42.2) 43 (37.7) 31 (33.3) 0.2
Maternal education levels >12 years 318 (57.8) 71 (62.3) 62 (66.7)
Table 2 Findings in multivariable analyses of associations 
between  reported early allergic conditions and  positive 
SPT at 18 months among GUSTO children
Adjusted OR in italics have a p value less than 0.05
a Adjusted for sex, ethnicity, maternal education levels, family history of allergy, 
vaginal delivery, breastfeeding, antibiotic consumption in the first 6 months 
of life, dog ownership, staying near an expressway, exposure to smoke at 
12 months
Risk factor N (%) Adjusteda OR (95 % CI)
Rhinitis reported before 
18 months of life
24 (25.5) 2.8 (1.1–7.3)
Wheeze reported before 
18 months of life
29 (29.0) 1.9 (0.8–4.5)
Eczema reported before 
18 months of life
40 (41.7) 4.5 (1.9–10.7)
Table 3 Findings in multivariable analyses of associations 
between  reported allergic conditions and  positive SPT 
at  36  months among  GUSTO children with  negative SPT 
at 18 months
Adjusted OR in italics have a p value less than 0.05
a Adjusted for sex, ethnicity, maternal education levels, family history of allergy, 
vaginal delivery, breastfeeding, antibiotic consumption in the first 6 months 
of life, dog ownership, staying near an expressway, exposure to smoke at 
12 months
Risk factor N (%) Adjusteda OR (95 % CI)
Rhinitis reported in the first 
18 months
8 (11.3) 1.3 (0.3–5.5)
Wheeze reported in the first 
18 months
29 (36.7) 3.2 (1.1–9.1)
Eczema reported in the first 
18 months
17 (21.0) 3.4 (1.2–9.3)
Rhinitis first reported after the first 
18 months
23 (25.8) 3.0 (1.05–8.3)
Wheeze first reported after the first 
18 months
10 (11.0) 1.0 (0.2–3.9)
Eczema first reported after the 
first18 months
4 (4.8) 0.5 (0.1–4.3)
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from 1.5 to 26 % in Germany [15] and 4–21 % in Korea 
[16]. The Korean study also reported a decrease in food 
allergen sensitization from 10 to 2 % [16]. These consist-
ent and opposite changes in sensitization patterns with 
age for inhalant and food allergens suggest that they may 
be independent of genetic and environmental factors.
Our observation that eczema was a predictor for aller-
gen sensitization at 18  months suggests that allergen 
sensitization may occur through an impaired skin bar-
rier. Stronger support for this suggestion is the fact that 
eczema preceded later allergen sensitization among chil-
dren not sensitized at 18  months. This combination of 
findings leads us to speculate that sensitization to aller-
gens may have occurred through an impaired (eczema-
tous) skin barrier in early life [17]. Of note, however, 
eczema with onset after 18  months was not associated 
with new allergen sensitization at 36 months.
Although eczema being a risk factor for allergen sen-
sitization has been reported, however knowledge on 
this in Asian countries is limited where genetic consti-
tution differs from the European countries, hence we 
performed this analysis in an Asian prospective birth 
cohort study. In agreement with our observations, the 
Melbourne Atopy Cohort Study, which recruited 552 at-
risk children, also showed that children with eczema in 
the first 6 months of life had elevated risk of developing 
new allergen sensitization at 1–2 years and proposed that 
sensitization may have occurred through a dysfunctional 
skin barrier [17]. Further evidence of the contribution 
of early-onset eczema to later allergen sensitization was 
provided by the Childhood Asthma Prevention Study 
(CAPS) in Australia, which followed more than 500 high-
risk children from birth to 5 years. That study found that 
eczema was an independent predictor of allergen sensiti-
zation by the age of 5 years among children who were not 
sensitized at 18 months [18]. Another study from Sweden 
reported that 80  % of children with eczema developed 
later sensitization to inhalant allergens [19]. Besides this, 
in another study of 373 high risk infants, persistent early 
onset eczema increased the risk of both aeroallergen 
and food allergen sensitization at 7  years [20]. Another 
German cohort study (n = 1314) also found that atopic 
dermatitis in first 3  months of life was a risk factor for 
aeroallergen sensitisation at 5 years [21].
Early eczema may also increase the risk of later food 
allergies. A study of 3-month-old infants from England 
and Wales reported that early onset of eczema was asso-
ciated with subsequent sensitization to foods [22]. Helen 
et al. [23] found that exposure to environmental peanut 
antigen in dust was a risk factor for later positive pea-
nut SPT; the odds increased in children with eczema and 
increased even further in children with severe eczema.
Other studies have reported similar results with other 
allergic outcomes. A study from Sweden that followed 
3124 children to 5  years reported that onset of eczema 
in the first year of life was associated with increased risk 
of developing asthma and rhinitis, while later onset of 
eczema was not [24]. De Benedetto [25] reviewed data 
suggesting that several epidermal alarmins may lead to 
a Th2 immune response when the skin barrier is com-
promised. Moreover, transient defects in the skin barrier 
may provide signals that lead to movement of Langerhans 
dendritic cells through tight junctions and engulfment of 
antigens present on the skin surface. Animal work also 
suggests that allergens such as house dust mites and food 
allergens can activate antigen-presenting cells in the epi-
dermis, leading to allergen sensitization and allergic dis-
eases [26]. Besides this, mutations in the filaggrin gene 
and filaggrin deficiency are known to increase the risk of 
development of eczema [27, 28] as filaggrin, an epidermal 
protein plays an essential role in maintaining the integrity 
of the epidermis by forming the corneocyte and regulat-
ing the hydration and pH levels of the stratum corneum 
[28]. Epidermal dysfunction allow entry of allergens, 
which can subsequently lead to allergen sensitisation 
[29].
We also found a significant association between 
early wheeze and new inhalant allergen sensitization at 
36  months. A possible mechanism is through the dis-
ruption of the airway epithelium that forms a physical 
barrier to entry of aeroallergens [30]. Asthmatic chil-
dren may have a defective airway epithelial barrier with 
reduced E-cadherin [31]. E-cadherin contributes to the 
structural integrity of the airway epithelium. Disruption 
of E-cadherin may compromise the function of the epi-
thelium in regulating the entry of aeroallergens, hence 
facilitating allergen sensitization [31].
The strengths of this study are the prospective study 
design with regular follow up and collection of data at 
multiple time points. In addition, skin prick testing 
is carried out at both 18–36  months which allow us to 
establish the temporal sequence between clinical phe-
notypes and allergen sensitization by looking at non-
sensitized children at 18  months. However the main 
limitation of the study is the parental report of allergic 
outcomes which may have resulted in some misclassifi-
cations. The study team tried to overcome this by calling 
up the subjects to ascertain if the parental reports are 
accurate.
In conclusion, we identified clinical phenotypes that 
may predispose a child to developing allergen sensitiza-
tion. Future research should assess whether improved 
clinical management of early-onset eczema and wheeze 
can reduce the risk of subsequent allergen sensitization.
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